Evidence map›Paper›PMID 37124032›Full record

ArticleFrontiers in cellular and infection microbiology2023

A case report: Severe disseminated infection caused by

Qinfu Xu, Xiaotong Xi, Dan Feng, Qian Sang, Yanbing Sheng, Ran Ding, Aiguo Xu

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Discovery of Polyphenolic Compounds fromCurrent computer-aided drug design · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Qinfu XuDepartment of Respiratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xiaotong XiThe State Key Laboratory of Translational Medicine and Innovative Drug Development, Nanjing, China.
Dan FengThe State Key Laboratory of Translational Medicine and Innovative Drug Development, Nanjing, China.
Qian SangDepartment of Respiratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Yanbing ShengDepartment of Respiratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Ran DingThe State Key Laboratory of Translational Medicine and Innovative Drug Development, Nanjing, China.
Aiguo XuDepartment of Respiratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
First Affiliated Hospital of Zhengzhou University · CNSimcere Pharmaceutical (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Case description: We report the case of a 75-year-old male patient with severe disseminated infection caused by Conclusion: The clinical manifestations of disease caused by infection with

Indexed as

Strongyloides stercoralisStrongyloidiasisAgedAnimalsHigh-Throughput Nucleotide SequencingHumansImmunocompromised HostMaleSputumcase reportdisseminated infectionimmunocompromisedmetagenomic next-generation sequencingStrongyloides stercoralis

Identifiers

PMID37124032
PMCPMC10140438
OpenAlexW4367600635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.